Novavax and Regeneron pop after landing grants from Uncle Sam. SiriusXM buys Stitcher (E.W. Scripps’ podcasting division) for $300 million. Bill Barker analyzes those stories, plus we hop in the wayback machine to revisit The Motley Fool’s (and Bill’s) role in helping the SEC pass “Regulation Fair Disclosure” resulting in a big victory for individual investors.
